Phase II trial of combination nab -paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma

Ajjai Alva*, Stephanie Daignault, David C. Smith, Maha Hussain

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of combination nab -paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences